ELEV
vs
ABBV
ELEV
ABBV
Over the past 12 months, ELEV has underperformed ABBV, delivering a return of -47% compared to the ABBV's +21% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ELEV
ABBV
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Elevation Oncology Inc
NASDAQ:ELEV
|
0.365
USD
|
|||||
|
Abbvie Inc
NYSE:ABBV
|
222.24
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
ELEV, ABBV
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Elevation Oncology Inc
Revenue
|
|||||||||||
|
Abbvie Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
ELEV, ABBV
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Elevation Oncology Inc
NASDAQ:ELEV
|
|||||||||
|
Abbvie Inc
NYSE:ABBV
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
ELEV, ABBV
Performance By Year
ELEV, ABBV
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.